Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Portenoy

Showing results (301-310 of 354) with videos related to

Pageof 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressR K Portenoy, H T Thaler, A B Kornblith, et al.
Neurology|September 1, 1991
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrationsR K Portenoy, E Khan, M Layman, et al.
Cancer|August 1, 1994
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptomsR K Portenoy, A B Kornblith, G Wong, et al.
Journal of Pain and Symptom Management|August 23, 2001
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer painR Payne, P Coluzzi, L Hart, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 28, 2015
Web-based symptom screening in cystic fibrosis patients: A feasibility studyJulie Balzano, Ashley Fresenius, Patricia Walker, et al.
Pain|March 6, 1999
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration studyR K Portenoy, R Payne, P Coluzzi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 1, 1994
Symptom prevalence, characteristics and distress in a cancer populationR K Portenoy, H T Thaler, A B Kornblith, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Journal of Pain and Symptom Management|June 21, 2005
Improving end-of-life care: development and pilot-test of a clinical pathwayMarilyn Bookbinder, Arthur E Blank, Elizabeth Arney, et al.
The Journal of Supportive Oncology|March 13, 2009
Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patientsNeal Slatkin, Jay Thomas, Arthur G Lipman, et al.
Pageof 36

Showing results (301-310 of 354) with videos related to

Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressR K Portenoy, H T Thaler, A B Kornblith, et al.
Neurology|September 1, 1991
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrationsR K Portenoy, E Khan, M Layman, et al.
Cancer|August 1, 1994
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptomsR K Portenoy, A B Kornblith, G Wong, et al.
Journal of Pain and Symptom Management|August 23, 2001
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer painR Payne, P Coluzzi, L Hart, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 28, 2015
Web-based symptom screening in cystic fibrosis patients: A feasibility studyJulie Balzano, Ashley Fresenius, Patricia Walker, et al.
Pain|March 6, 1999
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration studyR K Portenoy, R Payne, P Coluzzi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 1, 1994
Symptom prevalence, characteristics and distress in a cancer populationR K Portenoy, H T Thaler, A B Kornblith, et al.
Archives of Neurology|September 1, 1987
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancerR B Lipton, B S Galer, J P Dutcher, et al.
Journal of Pain and Symptom Management|June 21, 2005
Improving end-of-life care: development and pilot-test of a clinical pathwayMarilyn Bookbinder, Arthur E Blank, Elizabeth Arney, et al.
The Journal of Supportive Oncology|March 13, 2009
Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patientsNeal Slatkin, Jay Thomas, Arthur G Lipman, et al.
Pageof 36